# Johnson Matthey wins 5-year extension of Sarepta supply contract

Johnson Matthey has landed a 5-year extension of a contract with Sarepta Therapeutics to supply starting materials for PMO drug candidates at facilities in West Deptford, New Jersey, and Devens, Massachusetts.

- Type: Contract
- Announced: 2020-09-14
- Where: West Deptford, New Jersey; Devens, Massachusetts, United States
- Status: announced
- Products: phosphorodiamidate morpholino oligomer (PMO) starting materials
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Johnson Matthey](https://endata.com/companies/6652.md) (supplier)
- [Sarepta Therapeutics](https://endata.com/companies/49883.md) (customer)

## Sources

- [doi.org](https://doi.org/10.1021/cen-09835-buscon12), 2020-09-14: "The British chemical company Johnson Matthey has landed a 5-year extension of a contract with Sarepta Therapeutics to supply starting materials for the drug firm’s phosphorodiamidate morpholino oligomer (PMO) and peptide PMO drug candidates."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.